Skip to Content
Merck
  • Myosin I heavy chain kinase: cloning of the full-length gene and acidic lipid-dependent activation by Rac and Cdc42.

Myosin I heavy chain kinase: cloning of the full-length gene and acidic lipid-dependent activation by Rac and Cdc42.

Proceedings of the National Academy of Sciences of the United States of America (1999-01-20)
H Brzeska, R Young, U Knaus, E D Korn
ABSTRACT

Acanthamoeba myosin I heavy chain kinase (MIHCK) phosphorylates the heavy chains of amoeba myosins I, increasing their actin-activated ATPase activities. The activity of MIHCK is increased by binding to acidic phospholipids or membranes and by autophosphorylation at multiple sites. Phosphorylation at a single site is necessary and sufficient for full activation of the expressed catalytic domain. The rate of autophosphorylation of native MIHCK is controlled by a region N-terminal to the catalytic domain. By its substrate specificity and the sequence of its C-terminal catalytic domain, MIHCK was identified as a p21-activated kinase (PAK). We have now cloned the full-length genomic DNA and cDNA of MIHCK and have shown it to contain the conserved p21-binding site common to many members of the PAK family. Like some mammalian PAKs, MIHCK is activated by Rac and Cdc42, and this activation is GTP-dependent and accompanied by autophosphorylation. In contrast to mammalian PAKs, activation of MIHCK by Rac and Cdc42 requires the presence of acidic lipids. Also unlike mammalian PAK, MIHCK is not activated by sphingosine or other non-negatively charged lipids. The acidic lipid-binding site is near the N terminus followed by the p21-binding region. The N-terminal regulatory domain of MIHCK contains alternating strongly positive and strongly negative regions. and the extremely Pro-rich middle region of MIHCK has a strongly acidic N-terminal segment and a strongly basic C-terminal segment. We propose that autophosphorylation activates MIHCK by neutralizing the basic segment of the Pro-rich region, thus unfolding the regulatory domain and abolishing its inhibition of the catalytic domain.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Linoleic acid sodium salt, ≥98% (GC)
Avanti
Brain PS, Avanti Research - A Croda Brand
Avanti
Liver PI, Avanti Research - A Croda Brand
Avanti
Ceramide (Brain), Ceramide (Brain, Porcine), powder
Avanti
Liver PI, Avanti Research - A Croda Brand
Avanti
Brain PC, Avanti Research - A Croda Brand 840053C
Avanti
Brain PC, Avanti Research - A Croda Brand 840053P, powder
Avanti
Brain PS, Avanti Research - A Croda Brand